CASI PHARMACEUTICALS INC - COM (CASI)

CUSIP: 14757U109

Q4 2021 13F Holders as of 31 Dec 2021

Type / Class
Equity / COM
Total 13F shares
27,963,285
Share change
-2,733,165
Total reported value
$22,368,076
Price per share
$0.80
Number of holders
46
Value change
-$3,392,072
Number of buys
18
Number of sells
30

Quarterly Holders Quick Answers

What is CUSIP 14757U109?
CUSIP 14757U109 identifies CASI - CASI PHARMACEUTICALS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of CASI PHARMACEUTICALS INC - COM (CASI) as of Q4 2021

As of 31 Dec 2021, CASI PHARMACEUTICALS INC - COM (CASI) was held by 46 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 27,963,285 shares. The largest 10 holders included FEDERATED HERMES, INC., VANGUARD GROUP INC, Wellington Shields Capital Management, LLC, JACOBS LEVY EQUITY MANAGEMENT, INC, RENAISSANCE TECHNOLOGIES LLC, Ikarian Capital, LLC, BlackRock Inc., Wellington Shields & Co., LLC, GEODE CAPITAL MANAGEMENT, LLC, and SUSQUEHANNA INTERNATIONAL GROUP, LLP. This page lists 46 institutional shareholders reporting positions in this security for the Q4 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.